Tucker Asset Management’s Ginkgo Bioworks DNA Stock Holding History

Tucker Asset Management’s Portfolio DNA Stock Details DNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-9	Closed	-$75	–	541
2025 Q4	$75	Buy	+9	New	+$97	﹤0.01%	1057
2025 Q1	–	Sell	-9	Closed	-$88	–	456
2024 Q4	$88	Hold	9	–	–	﹤0.01%	1488
2024 Q3	$73	Hold	9	–	–	﹤0.01%	1407
2024 Q2	$124	Hold	9	–	–	﹤0.01%	1591
2024 Q1	$429	Hold	9	–	–	﹤0.01%	1510
2023 Q4	$625	Sell	9 -10	-53%	-$612	﹤0.01%	1301
2023 Q3	$1.39K	Sell	19 -6	-24%	-$480	﹤0.01%	1103
2023 Q2	$1.86K	Buy	+25	New	+$1.48K	﹤0.01%	876

Other funds holding DNA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

ACG

Anchorage Capital Group New York $450M AUM 41.75% 1-Year Est. Return

EAM

Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JMFC

J.M. Forbes & Co Boston, Massachusetts $1.27B AUM 26.46% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Tucker Asset Management's DNA Position: Q1 2026 in Review

Tucker Asset Management sold out of Ginkgo Bioworks (DNA) in Q1 2026, closing a stake of 9 shares — an estimated $75 sold.

Tucker Asset Management first reported a position in DNA in Q2 2023 and held it in 8 quarters. The position peaked at $1.86K in Q2 2023. 175 funds tracked by Wall St. Rank hold DNA as of Q1 2026.

Tucker Asset Management reported no remaining Ginkgo Bioworks position as of Q1 2026 after selling out during the quarter.
Tucker Asset Management sold 9 Ginkgo Bioworks shares in Q1 2026, an estimated $75.
Tucker Asset Management first reported a position in Ginkgo Bioworks in Q2 2023 and held it in 8 quarters.
Tucker Asset Management's Ginkgo Bioworks position peaked at $1.86K in Q2 2023.
175 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q1 2026.

Based on Tucker Asset Management's 13F filing for Q1 2026, filed 27 Aug 2026.